Rh Antibody Titration Test
1. Objective:
To determine the concentration (titer) of anti-D (Rh) antibodies in a patient's serum—especially in Rh-negative pregnant women—to assess risk of Hemolytic Disease of the Fetus and Newborn (HDFN).
2. Principle:
Serial dilutions of the patient’s serum are reacted with Rh-positive red cells. The highest dilution at which agglutination still occurs is the antibody titer. This provides a quantitative estimate of antibody strength.
3. Materials Required:
Patient's serum
Rh(D) positive red blood cells (usually R1R1)
Phosphate-buffered saline (PBS)
2–5% red cell suspension
Incubator at 37°C
Centrifuge
Test tubes
Antihuman globulin (AHG or Coombs reagent)
4. Procedure:
Prepare serial twofold dilutions of the patient’s serum (e.g., 1:1 to 1:1024).
Add equal volume of 2–5% Rh(D)-positive RBC suspension.
Incubate at 37°C for 30–60 minutes.
Wash cells 3–4 times with PBS.
Add AHG reagent, centrifuge, observe for agglutination.
The highest dilution showing 1+ agglutination or stronger is recorded as the titer.
5. Result Interpretation:
Titer ≥16–32: Potential risk of HDFN, requires close monitoring.
Titer rising over time: Indicates active alloimmunization.
Stable or low titer: Lower risk, but monitor.
6. Clinical Relevance:
Helps guide obstetric management in Rh-incompatible pregnancies.
Determines need for intrauterine transfusion or early delivery
Comments
Post a Comment